These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31753231)

  • 1. Rectal Cancer: Assessing Response to Neoadjuvant Therapy.
    Maas M; Dijkhoff RAP; Beets-Tan R
    Magn Reson Imaging Clin N Am; 2020 Feb; 28(1):117-126. PubMed ID: 31753231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
    Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI for Rectal Cancer Primary Staging and Restaging After Neoadjuvant Chemoradiation Therapy: How to Do It During Daily Clinical Practice.
    Cianci R; Cristel G; Agostini A; Ambrosini R; Calistri L; Petralia G; Colagrande S
    Eur J Radiol; 2020 Oct; 131():109238. PubMed ID: 32905955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary and post-chemoradiotherapy staging using MRI in rectal cancer: the role of diffusion imaging in the assessment of perirectal infiltration.
    Fornell-Perez R; Perez-Alonso E; Porcel-de-Peralta G; Duran-Castellon A; Vivas-Escalona V; Aranda-Sanchez J; Gonzalez-Dominguez MC; Rubio-Garcia J; Aleman-Flores P; Lozano-Rodriguez A; Orihuela-de-la-Cal ME; Loro-Ferrer JF
    Abdom Radiol (NY); 2019 Nov; 44(11):3674-3682. PubMed ID: 31332499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of percent change in tumoral volume measured at T
    Quaia E; Gennari AG; Ricciardi MC; Ulcigrai V; Angileri R; Cova MA
    J Magn Reson Imaging; 2016 Dec; 44(6):1415-1424. PubMed ID: 27219471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response assessment after (chemo)radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy?
    van der Sande ME; Beets GL; Hupkens BJ; Breukink SO; Melenhorst J; Bakers FC; Lambregts DM; Grabsch HI; Beets-Tan RG; Maas M
    Eur J Surg Oncol; 2019 Jun; 45(6):1011-1017. PubMed ID: 30528891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy.
    Cote A; Florin FG; Mois E; Elisei R; Badea R; Mare C; Hajjar NA; Iancu C; Lebovici A
    Ann Ital Chir; 2018; 89():168-176. PubMed ID: 29848812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative concurrent chemoradiotherapy MRI characteristics favouring pathologic complete response in patients with rectal cancer: Usefulness of MR T2-stage as an ancillary finding for predicting pathologic complete response.
    Lee HJ; Chung WS; An JH; Kim JH
    J Med Imaging Radiat Oncol; 2021 Apr; 65(2):166-174. PubMed ID: 33319450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer.
    van Griethuysen JJM; Lambregts DMJ; Trebeschi S; Lahaye MJ; Bakers FCH; Vliegen RFA; Beets GL; Aerts HJWL; Beets-Tan RGH
    Abdom Radiol (NY); 2020 Mar; 45(3):632-643. PubMed ID: 31734709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image Quality Assessment of 2D
    Hausmann D; Liu J; Budjan J; Reichert M; Ong M; Meyer M; Smakic A; Grimm R; Strecker R; Schoenberg SO; Wang X; Attenberger UI
    Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of pathological complete response to preoperative chemoradiotherapy by means of multiple mathematical models of diffusion-weighted MRI in locally advanced rectal cancer: A prospective single-center study.
    Zhu HB; Zhang XY; Zhou XH; Li XT; Liu YL; Wang S; Sun YS
    J Magn Reson Imaging; 2017 Jul; 46(1):175-183. PubMed ID: 27981667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.
    Kim SH; Lee JM; Hong SH; Kim GH; Lee JY; Han JK; Choi BI
    Radiology; 2009 Oct; 253(1):116-25. PubMed ID: 19789256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy.
    Horvat N; Veeraraghavan H; Khan M; Blazic I; Zheng J; Capanu M; Sala E; Garcia-Aguilar J; Gollub MJ; Petkovska I
    Radiology; 2018 Jun; 287(3):833-843. PubMed ID: 29514017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of volumetric apparent diffusion coefficient histogram analysis for assessing complete response and clinical outcomes following pre-operative chemoradiation treatment for rectal carcinoma.
    Chidambaram V; Brierley JD; Cummings B; Bhayana R; Menezes RJ; Kennedy ED; Kirsch R; Jhaveri KS
    Abdom Radiol (NY); 2017 May; 42(5):1310-1318. PubMed ID: 28004138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
    Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
    Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
    Wang Y; Chen G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of functional magnetic resonance imaging in predicting outcomes of neoadjuvant chemoradiotherapy in rectal cancer].
    Yu Y; Yue J; Yu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):491-494. PubMed ID: 28534322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of reassessment after neoadjuvant therapy and difficulties in interpretation.
    Pierredon-Foulongne MA; Nougaret S; Bibeau F; Rouanet P; Delhom E; Lonjon J; Ragu N; Colleau J; Schembri V; Guiu B; Gallix B
    Diagn Interv Imaging; 2014 May; 95(5):495-503. PubMed ID: 24767672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.